Glycosphingolipids

DBCAT002998Pharmacologic class

Lipids containing at least one monosaccharide residue and either a sphingoid or a ceramide (CERAMIDES). They are subdivided into NEUTRAL GLYCOSPHINGOLIPIDS comprising monoglycosyl- and oligoglycosylsphingoids and monoglycosyl- and oligoglycosylceramides; and ACIDIC GLYCOSPHINGOLIPIDS which comprises sialosylglycosylsphingolipids... A DrugBank category of 6 drugs.

Also known as: Asialogangliosides · Sphingoglycolipids
Drugs: ABX-196
Alpha-galactosylceramide
Ceramide AP
Ceramide NG
Siagoside
Sulfatide

What you can answer from here — as of November 01, 2016

6DrugsEach linked to its full drug card

Listed above

7Drug targetsEvery drug–target pair in the class, with bond type

2Marketed productsAcross the regions we cover, with dosage forms and routes

2Routes of administrationHow the drugs in this class are given

Which targets do Glycosphingolipids share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account